Literature DB >> 15674424

Dendritic cells in MDS and AML--cause, effect or solution to the immune pathogenesis of disease?

N Panoskaltsis1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15674424     DOI: 10.1038/sj.leu.2403634

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

Review 2.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

3.  Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis.

Authors:  Haifeng Zhuang; Yu Chen; Xianfu Sheng; Lili Hong; Ruilan Gao; Xiaofen Zhuang
Journal:  PeerJ       Date:  2020-06-25       Impact factor: 2.984

Review 4.  The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia.

Authors:  Hooriyeh Shapoorian; Hamidreza Zalpoor; Mazdak Ganjalikhani-Hakemi
Journal:  Blood Sci       Date:  2021-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.